BioCentury | Dec 20, 2010
Financial News

NovImmune financial update

...raised CHF20 million ($20.3 million) in an extension of a series B round. Existing investor BZ Bank...
BioCentury | Dec 18, 2010
Financial News

NovImmune adds $20.4 million

...CHF20 million ($20.4 million) in an extension of a series B round from existing investor BZ Bank...
BioCentury | Sep 13, 2010
Financial News

Pevion Biotech Ltd. completes venture financing

...Business: Infectious, Cancer Date completed: 9/7/10 Type: Venture financing Raised: CHF10 million ($9.8 million) Investors: BZ Bank...
BioCentury | Sep 8, 2010
Financial News

Pevion raises CHF10 million

...Ittigen, Switzerland) raised CHF10 million ($9.8 million) in a private round led by existing investor BZ Bank...
BioCentury | May 12, 2009
Top Story

NovImmune raises $56.4 million

...Geneva, Switzerland) raised CHF62.5 million ($56.4 million) in an equity financing led by existing investor BZ Bank...
BioCentury | Sep 17, 2007
Company News

Pevion Biotech board of directors update

...Klaus Breiner, venture capital investor at BB Biotech Ventures; and Joseph Manko, investment banker for BZ Bank...
BioCentury | Aug 11, 2007
Financial News

Pevion raises $29.4 million

...raised CHF 35 million ($29.4 million) in a series A round led by new investor BZ Bank...
BioCentury | Nov 13, 2006
Strategy

Expanding the envelope

...as start Phase I/IIa trials with NI-0701." The B round was led by new investor BZ Bank...
BioCentury | Oct 31, 2006
Financial News

NovImmune raises $46.1 million

...Switzerland) raised CHF58 million ($46.1 million) in a series B round led by new investor BZ Bank...
Items per page:
1 - 9 of 9
BioCentury | Dec 20, 2010
Financial News

NovImmune financial update

...raised CHF20 million ($20.3 million) in an extension of a series B round. Existing investor BZ Bank...
BioCentury | Dec 18, 2010
Financial News

NovImmune adds $20.4 million

...CHF20 million ($20.4 million) in an extension of a series B round from existing investor BZ Bank...
BioCentury | Sep 13, 2010
Financial News

Pevion Biotech Ltd. completes venture financing

...Business: Infectious, Cancer Date completed: 9/7/10 Type: Venture financing Raised: CHF10 million ($9.8 million) Investors: BZ Bank...
BioCentury | Sep 8, 2010
Financial News

Pevion raises CHF10 million

...Ittigen, Switzerland) raised CHF10 million ($9.8 million) in a private round led by existing investor BZ Bank...
BioCentury | May 12, 2009
Top Story

NovImmune raises $56.4 million

...Geneva, Switzerland) raised CHF62.5 million ($56.4 million) in an equity financing led by existing investor BZ Bank...
BioCentury | Sep 17, 2007
Company News

Pevion Biotech board of directors update

...Klaus Breiner, venture capital investor at BB Biotech Ventures; and Joseph Manko, investment banker for BZ Bank...
BioCentury | Aug 11, 2007
Financial News

Pevion raises $29.4 million

...raised CHF 35 million ($29.4 million) in a series A round led by new investor BZ Bank...
BioCentury | Nov 13, 2006
Strategy

Expanding the envelope

...as start Phase I/IIa trials with NI-0701." The B round was led by new investor BZ Bank...
BioCentury | Oct 31, 2006
Financial News

NovImmune raises $46.1 million

...Switzerland) raised CHF58 million ($46.1 million) in a series B round led by new investor BZ Bank...
Items per page:
1 - 9 of 9